International Classification of Diseases

ENDRA Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

Retrieved on: 
Thursday, March 28, 2024
Oncology, Health, FDA, Clinical Trials, Pharmaceutical, Biotechnology, Diagnosis, De novo, PIN, Obesity, MRI, Syndrome, Metabolism, KCH, Knowledge Organization (journal), International, National Health Service, NHS, Research, Radiology, MASH, Trial of the century, International Classification of Diseases, Hepatology, World Health Organization, Data collection, Prediabetes, NDRA, Liver, Type 2 diabetes, Liver disease, Marketing, NAFLD, Endocrinology, Video game

ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), today reports financial results for the three months and year ended December 31, 2023 and provides a business update.

Key Points: 
  • ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), today reports financial results for the three months and year ended December 31, 2023 and provides a business update.
  • Highlights from the fourth quarter of 2023 and recent weeks include:
    Installed first TAEUS system in the UK at King’s College Hospital for clinical evaluation.
  • In the third quarter of 2023, ENDRA submitted a De Novo request for its TAEUS liver system to the FDA.
  • In the fourth quarter of 2023, the FDA issued an Additional Information (AI) request to ENDRA.

New ICD-10-CM Code by the World Health Organization Paves the Way for Improved NAFLD Diagnostics Including ENDRA Life Sciences’ TAEUS System

Retrieved on: 
Wednesday, February 21, 2024
FDA, Health, Diabetes, Surgery, Health Insurance, Pharmaceutical, Therapy, CE, American Diabetes Association, NAFLD, Endocrinology, T2D, Research, Medicine, Person, CMS, Non-alcoholic fatty liver disease, Liver disease, NDRA, Prediabetes, Obesity, Cardiovascular disease, Food, ALT, De novo, Global health, Weill Cornell Medicine, Risk, Hepatology, Cirrhosis, European, Prevalence, Ultrasound, World Health Organization, Medicare, Type 2 diabetes, Metabolic syndrome, Patient, Fibrosis, Primary care, Fatty liver disease, NASH, Diagnosis, Knowledge Organization (journal), WHO, International Classification of Diseases, Dietary supplement

The International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM), is a global coding system used to indicate a diagnosis for reimbursement purposes.

Key Points: 
  • The International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM), is a global coding system used to indicate a diagnosis for reimbursement purposes.
  • These codes are issued by the World Health Organization (WHO) and are used to show payers why a particular service was medically necessary.
  • The inclusion of NAFLD under the ICD-10 K76.0 code facilitates standardized billing for its diagnosis.
  • "This positive development is testament to the growing awareness of liver health and the intensifying need for effective diagnostic solutions.

Voya Financial expands its workplace benefits offerings with new supplemental health insurance solution

Retrieved on: 
Wednesday, February 21, 2024
Technology, Professional Services, Health, Health Technology, Health Insurance, Asset Management, Apps, Applications, Software, Insurance, Human Resources, Finance, Diabetes, Anxiety, Emergency, Mental health, Workplace, Voya Financial, Bipolar disorder, Concussion, Asthma, ICD-10, Stroke, Family, DSM-IV codes, Epilepsy, International Classification of Diseases, Knowledge Organization (journal), Ageing, Research, Protection, Health insurance

Voya Financial, Inc. (NYSE: VOYA), announced today that it continues to enhance its growing portfolio of workplace benefits by offering an innovative, technology-enabled solution to help employees ease the burden of out-of-pocket medical costs.

Key Points: 
  • Voya Financial, Inc. (NYSE: VOYA), announced today that it continues to enhance its growing portfolio of workplace benefits by offering an innovative, technology-enabled solution to help employees ease the burden of out-of-pocket medical costs.
  • Voya Protect, a new Group Limited Benefit Insurance powered by the insurance technology company Ansel Health, is a supplemental health offering that is designed to pay benefits quickly and easily when covered conditions are diagnosed.
  • And, while many employers have made changes to their benefit lineups to help support their employees, the reality is that workplace benefits are complex,” explained Nate Black, vice president, Health Solutions Product at Voya Financial.
  • Voya Protect is the latest example of how Voya is focused on providing innovative solutions and capabilities to help employers and their employees optimize their workplace benefits and savings needs.

FERRIS INTRODUCES iCD+ CUTTING SYSTEM

Retrieved on: 
Wednesday, October 18, 2023
Vacuum, Locator, Briggs & Stratton, International Classification of Diseases, Marketing, Amusement park

MILWAUKEE, Oct. 18, 2023 /PRNewswire/ -- Ferris Mowers has taken its popular iCD™ Cutting System and upgraded it for even better efficiency and a superior cut. The new iCD+ Cutting System, launching at Equip Exposition in Louisville, Kentucky will be available on Ferris units this fall. The new system will be available on the Ferris® ISX™800, ISX2200, ISX3300 and ISX6200 zero turns as well as the Ferris Z2 and Z3X stand-on units.

Key Points: 
  • MILWAUKEE, Oct. 18, 2023 /PRNewswire/ -- Ferris Mowers has taken its popular iCD™ Cutting System and upgraded it for even better efficiency and a superior cut.
  • The new iCD+ Cutting System, launching at Equip Exposition in Louisville, Kentucky will be available on Ferris units this fall.
  • The new system will be available on the Ferris® ISX™800, ISX2200, ISX3300 and ISX6200 zero turns as well as the Ferris Z2 and Z3X stand-on units.
  • The new iCD+ Cutting System will be on display at the 2023 Equip Exposition in booth 5016.

The MOG Project, Pediatric Neurologist Secure CDC Approval to Adopt ICD-10 Code for Rare Disease MOGAD

Retrieved on: 
Monday, October 2, 2023
Insurance, Optic neuritis, General assembly, Disease, United Nations, Glycoprotein, CHLA, Neuroimmunology, ICD, Lou Ruvo Center for Brain Health, Knowledge Organization (journal), United Nations General Assembly, Centers for Disease Control and Prevention, Research, Brain, Children's Hospital, Multiple sclerosis, CDC, MOGAD, MD, Patient, Physician, Children's Hospital Los Angeles, Immune system, Optic nerve, Stockholm Environment Institute US Center, Transverse myelitis, Diagnosis, Knowledge, Neuromyelitis optica spectrum disorder, Barrow Neurological Institute, International Classification of Diseases, Video game–related health problems, FDA, Acute disseminated encephalomyelitis, WHO, World Health Organization, Medical device

OLNEY, Md., Oct. 2, 2023 /PRNewswire-PRWeb/ -- The MOG Project, a nonprofit organization committed to supporting the research and treatment of Myelin Oligodendrocyte Glycoprotein Antibody Disease (MOGAD) announced that its Executive Director Julia Lefelar, with support from The MOG Project Executive Board and Children's Hospital Los Angeles (CHLA) Pediatric Neurologist Jonathan Santoro, MD, secured approval to have the US Centers for Disease Control and Prevention (CDC) create an ICD-10 code for MOGAD. As of October 1, 2023, an official code for MOGAD is included in the 10th edition of the International Classification of Diseases (ICD) and Related Health Problems, which is relied upon by physicians and insurance providers to classify diagnoses and advise treatment.

Key Points: 
  • Without a CDC code, MOGAD patients had previously been grouped in with patients with similar diseases like neuromyelitis optica spectrum disorder, optic neuritis, acute disseminated encephalomyelitis, transverse myelitis and even multiple sclerosis.
  • "For the MOGAD community, this CDC code is more than a win for better health outcomes and fewer insurance delays, it gives our rare disease an identity and legitimizes it."
  • "The addition of a MOGAD specific ICD-10 code allows patients to better access the therapies that they need to treat their disease," said Santoro.
  • "Further, it allows for disease monitoring across the country, which will increase knowledge and research on this rare neuroimmunology disorder."

Rhythm Pharmaceuticals Announces New ICD-10 Diagnosis Code Established for Bardet-Biedl Syndrome

Retrieved on: 
Wednesday, September 6, 2023
Polyphagia, Obesity, International Classification of Diseases, Prevalence, Bardet–Biedl syndrome, Deficit spending, Visual impairment, Knowledge Organization (journal), Brain, CDC, BBS, HIV disease progression rates, Patient, Physician, Syndrome, Korea Disease Control and Prevention Agency, Hypothalamus, MC4R, Diagnosis, Hunger, News, Hypogonadism, Polydactyly, Disease, Pharmaceutical industry, Nursing

The new code, Q87.83 Bardet-Biedl syndrome (BBS), takes effect Oct. 1, 2023.

Key Points: 
  • The new code, Q87.83 Bardet-Biedl syndrome (BBS), takes effect Oct. 1, 2023.
  • “Finding and connecting patients, families and physicians across the country has been extremely challenging because of the lack of a dedicated ICD-10 code as patients with BBS are lumped in with many other genetic syndromes,” said Tim Ogden, President of the BBS Foundation.
  • “We believe this new disease specific ICD-10 code marks an important advance for the care of patients with BBS,” said Jennifer Chien, Rhythm Executive Vice President and Head of North America.
  • People living with BBS also may experience cognitive impairment, polydactyly, renal dysfunction, hypogonadism, and visual impairment.

LSUS Alumni Create Medical Coding Chatbot to Reduce Time, Improve Accuracy

Retrieved on: 
Tuesday, August 22, 2023
Heart, Insurance, Medicine, Disease, Health, LSUS, Learning curve, Cancer, ICD, Intelligence, Knowledge Organization (journal), Research, Discord, Student, Machine learning, Microsoft Excel, CPA, AI, Patient, Social media, International Classification of Diseases, Software, Medical device, Nursing, Customer service

SHREVEPORT, La., Aug. 22, 2023 /PRNewswire/ -- LSUS alumni developed an innovative medical coding chatbot that is designed to reduce time and improve accuracy of medical coding.

Key Points: 
  • SHREVEPORT, La., Aug. 22, 2023 /PRNewswire/ -- LSUS alumni developed an innovative medical coding chatbot that is designed to reduce time and improve accuracy of medical coding.
  • Medical coders typically endure months of training, but the medical coding chatbot could lessen that learning curve and better prepare coders.
  • This free platform could introduce the medical coding chatbot to a wider audience than other paid platforms like Slack.
  • Medical professionals wanting to test the medical coding chatbot: https://discord.gg/x5BXTPqG7U

Crises of workplace burnout and climate change share common cause and must be tackled together, announces green CEO Chris Caldwell of United Renewables

Retrieved on: 
Wednesday, December 14, 2022
Effects of climate change on human health, Knowledge Organization (journal), Caldwell, International Classification of Diseases, Biodiversity, Policy, Climate change, Isle, Climate, Logic, Wind, Mental health, Renewable energy, Agriculture

DOUGLAS, Isle of Man, Dec. 14, 2022 (GLOBE NEWSWIRE) -- 20th century models of industrial management are in need of urgent reform if developed economies are to solve the twin problems of worker burnout and global heating, argues green energy CEO Chris Caldwell in a new article published today (‘Burning out and burning up’).

Key Points: 
  • Caldwell is himself an entrepreneur and CEO in the cleantech industry at United Renewables , with over two decades experience leading diverse global teams developing renewable energy projects across wind, solar, tidal and anaerobic.
  • Beyond his experience leading businesses in the sector, he is also host of the podcast Conversations on Climate .
  • Conversations on Climate brings world-leading thinkers from business and academia together to share their expertise on the subject of climate change.
  • Previous guests include Sir Andrew Likierman , Julio Dal Poz , Professor Jean-Pierre Beno ît , Professor Ioannou , Tara Schmidt , and Professor Dan Cable .

Study Examines Total Knee Replacement in Patients Under 21

Retrieved on: 
Sunday, November 13, 2022
Magnet, Hospital for Special Surgery, MS, Health, Malignancy, Therapy, American College of Rheumatology, Knowledge Organization (journal), KID, Agency for Healthcare Research and Quality, U.S. News & World Report, Physician, TKA, Quality, American Nurses Credentialing Center, The Hospital, ACR, Hospital, MPH, Weill Cornell Medicine, Nursing, Agency, International Classification of Diseases, Neoplasm, Population, Organization, Infection, Kid, Research, HSS, Cancer, Long Island, ICD-9, Elective surgery, Female, JIA, Interval (mathematics), Multimedia, News, Trauma, Laboratory, Education, Rheumatology, American College, Data, Patient, Juvenile idiopathic arthritis, Inflammatory arthritis, Dentistry, Medical imaging, Medicine, MD, Newsweek, MBBS

PHILADELPHIA, Nov. 13, 2022 /PRNewswire/ -- A new study from researchers at Hospital for Special Surgery (HSS) has evaluated trends in the use of total knee arthroplasty (TKA) in patients under 21 in the United States.

Key Points: 
  • PHILADELPHIA, Nov. 13, 2022 /PRNewswire/ -- A new study from researchers at Hospital for Special Surgery (HSS) has evaluated trends in the use of total knee arthroplasty (TKA) in patients under 21 in the United States.
  • However, the number of patients under the age of 21 undergoing TKA in the U.S. is unknown.
  • The total weighted number of TKAs performed in patients younger than 21 from 2000-2016 was 1,331; the number of TKAs performed per year in this age group remained relatively stable.
  • "Our study was able to confirm that tumors were the most common reason for knee arthroplasty in this population."

Verana Health to Present Abstract at American Statistical Association's Biopharmaceutical Section Regulatory-Industry Statistics Workshop

Retrieved on: 
Monday, September 19, 2022
MPH, American Academy, American Statistical Association, ASA, Selection bias, FDA, Research, Laika (EHR testing framework), Data management, Machine Intelligence Research Institute, Industry, Health information management, Missing data, Patient, ICD, DR, American Academy of Neurology, Technology, Quality of life, Knowledge Organization (journal), Severe cognitive impairment, American Urological Association, Solution, HCP, Doctor of Philosophy, International Classification of Diseases, Record, Diabetic retinopathy, Method, HCPS, SAN, Medicine, American Academy of Ophthalmology, Health, HIV disease progression rates, Electronic health record, EHR, Pharmaceutical industry, Medical device, Ophthalmology

SAN FRANCISCO, Sept. 19, 2022 /PRNewswire/ -- Verana Health®—a digital health company elevating quality in real-world data—will present an abstract at the American Statistical Association's (ASA) Biopharmaceutical Section Regulatory-Industry Statistics Workshop on Sept. 21 in Rockville, Md.

Key Points: 
  • SAN FRANCISCO, Sept. 19, 2022 /PRNewswire/ -- Verana Health a digital health company elevating quality in real-world datawill present an abstract at the American Statistical Association's (ASA) Biopharmaceutical Section Regulatory-Industry Statistics Workshop on Sept. 21 in Rockville, Md.
  • A team of nine Verana Health researchers sought to understand the mechanism of missingness for DR disease severity.
  • Verana Health is a digital health company elevating quality in real-world data.
  • Using its clinician-informed and artificial intelligence-enhanced VeraQpopulation health data engine, Verana Health transforms structured and unstructured healthcare data into curated, disease-specific data modules, Qdata.